Skip to main content
EYENational Vision Holdings, Inc.Hold5.9·$17.50-2.56%
Open full analysis

National Vision Holdings, Inc. (EYE) Stock Analysis

Recovery setup

HoldModerate Confidence

Consumer Cyclical · Specialty Retail

Hold if already holding. Not a fresh buy at $17.50, but acceptable to hold if already in. Reasons: Elevated risk factors; Below 200-MA, MA slope -3.5%/30d (confirmed downtrend).

National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations), Eyeglass World (122 locations), and two Vista Optical host brands — throughout the United States. The company sells eye exams, eyeglasses, and contact lenses,... Read more

$17.50+45.0% A.UpsideScore 5.9/10#7 of 18 Specialty Retail
QualityF-score8 / 9FCF yield8.87%
Stop $16.34Target $25.47(analyst − 13%)A.R:R 3.0:1
Analyst target$29.27+67.3%11 analysts
$25.47our TP
$17.50price
$29.27mean
$39

Hold if already holding. Not a fresh buy at $17.50, but acceptable to hold if already in. Reasons: Elevated risk factors; Below 200-MA, MA slope -3.5%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 56. Mixed signals. Hold existing position. Score 5.9/10, moderate confidence.

Passes 8/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 49d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

10-K grounded · weekly refresh

About National Vision Holdings, Inc.

About National Vision Holdings, Inc.

National Vision Holdings operated 1,250 retail optical stores across four brands at fiscal year-end January 3, 2026, with America's Best at 1,057 locations forming the core owned brand and Eyeglass World at 122 locations as the secondary format. Managed care insurance billing represented 42% of revenues from continuing operations in 2025, and omni-channel plus e-commerce platforms contributed approximately 7% of net revenue. The company opened 33 new stores in fiscal 2025 and targets 30 to 35 openings in fiscal 2026, with plans to reaccelerate to roughly 60 openings per year beginning 2028 for a total of approximately 240 new stores through 2030.

National Vision earns revenue through direct retail sales of frames and lenses, contact lens sales, and eye exam services provided by employed or contracted optometrists. The Eyecare Club subscription program — with approximately 1.3 million active members at January 3, 2026 — offers two eye exams per year plus a 10% discount for a one-time fixed multi-year fee, driving repeat traffic and contact lens refills. Supply is concentrated: EssilorLuxottica holds the sole and exclusive right to supply certain eyeglass lenses to National Vision under an agreement that runs through May 2028, while CooperVision manufactures the company's private label contact lens brands (Sofmed and Natural Eyes HydraWear). New store economics target a cash investment of $0.4 million to $0.6 million per location, with fifth-year sales of $1.5 million to $1.7 million and capital payback in three to five years. Competition spans independent optical retailers (roughly half the industry), mass merchants, warehouse clubs, specialty chains, and online contact lens sellers.

Show full overview

National Vision's managed care exposure at 42% of continuing operations revenues creates a dependency on vision insurance network admissions. The 10-K acknowledges that competition in managed care is based on price and network density and that the company may face heightened challenges to be admitted or to maintain status in managed care provider networks. Separately, the EssilorLuxottica sole-supply lens agreement expires in May 2028, creating a renegotiation event that could affect lens cost structure if renewal terms shift — a risk that compounds the managed care exposure since lens margin is a key driver of the value proposition to insurance-paying customers.

See also: Consumer Cyclical · Specialty Retail

From National Vision Holdings, Inc.'s most recent 10-K filing, extracted June 10, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-17
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Aug 5, 202649d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Strong growth profile
Risks
Elevated risk factors
Below 200-MA, MA slope -3.5%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)30.8
P/E (Fwd)14.8
Mkt Cap$1.4B
EV/EBITDA11.5
Profit Mgn2.3%
ROE5.4%
Rev Growth6.6%
Beta1.07
DividendNone
Rating analysts16

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C3.00bearish
IV119%elevated
Max Pain$25+42.9% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.6
Value Rank
3.9
Growth Rank
3.9

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
1.7
Bollinger
3.0
Support Resistance
3.8
Gap
6.0
GatesDeath cross (50MA < 200MA)Momentum 6.0>=5.5A.R:R 3.0 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 49d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
56 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $14.93Resistance $19.18

Price Targets

$16
$25
A.Upside+45.5%
A.R:R3.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Analyst Consensus

Analysts16
Consensus4.1/5
Avg Target$29

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-05 (49d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is EYE stock a buy right now?

Hold if already holding. Not a fresh buy at $17.50, but acceptable to hold if already in. Reasons: Elevated risk factors; Below 200-MA, MA slope -3.5%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 56. Mixed signals. Hold existing position. Target $25.47 (+45.5%), stop $16.34 (−7.1%), A.R:R 3.0:1. Score 5.9/10, moderate confidence.

What is the EYE stock price target?

Take-profit target: $25.47 (+45.0% upside). Target $25.47 (+45.5%), stop $16.34 (−7.1%), A.R:R 3.0:1. Stop-loss: $16.34.

What are the risks of investing in EYE?

Elevated risk factors; Below 200-MA, MA slope -3.5%/30d (confirmed downtrend).

Is EYE overvalued or undervalued?

National Vision Holdings, Inc. trades at a P/E of 30.8 (forward 14.8). TrendMatrix value score: 8.0/10. Verdict: Hold.

What do analysts say about EYE?

16 analysts cover EYE with a consensus score of 4.1/5. Average price target: $29.

What does National Vision Holdings, Inc. do?National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations),...

National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations), Eyeglass World (122 locations), and two Vista Optical host brands — throughout the United States. The company sells eye exams, eyeglasses, and contact lenses, with managed care insurance billing representing 42% of revenues from continuing operations in 2025. EssilorLuxottica holds the sole and exclusive right to supply certain eyeglass lenses under a contract running through May 2028.

Related stocks: MNSO (MINISO Group Holding Limited) · FIVE (Five Below, Inc.) · BBWI (Bath & Body Works, Inc.) · MUSA (Murphy USA Inc.) · SBH (Sally Beauty Holdings, Inc. (Na)
Home Stocks EYE

Latest news

Latest News

Investing.com63d ago
TradingView35d agoEarnings
Seeking Alpha35d agoEarnings
Moomoo35d ago
MSN35d ago
Yahoo Finance35d agoEarnings
GuruFocus35d agoEarnings
Investing.com35d agoEarnings
Marketscreener.com35d agoEarnings
Marietta Daily Journal35d agoEarnings
The Rome News-Tribune35d agoEarnings
10TV35d agoEarnings
KING5.com35d agoEarnings
KTVB35d agoEarnings
WKYC35d agoEarnings
Investing.com Canada42d agoEarnings
Fox Business64d ago
Schaeffer's Investment Research64d ago
The New York Times64d ago
GuruFocus64d ago
Loading more...